Are you Dr. Eshleman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Baltimore, MD 21287
Summary
- Dr. Susan Eshleman, MD is a board certified pathologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Ohio. She is affiliated with Johns Hopkins Hospital and is a Professor of Pathology at HIV Prevention Trials Network (HPTN) Network Laboratory.
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1988 - 1993- University of Pennsylvania Health SystemInternship, Internal Medicine, 1987 - 1988
Perelman School of Medicine at the University of PennsylvaniaClass of 1987
Certifications & Licensure
MD State Medical License 1997 - 2026
OH State Medical License 1993 - 1998- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 7 citationsValidation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.Ethan Klock, Ethan Wilson, Reinaldo E Fernandez, Estelle Piwowar-Manning, Ayana Moore
Journal of the International AIDS Society. 2021-12-01 - 7 citationsExtended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.Mark A Marzinke, Jessica M Fogel, Zhe Wang, Estelle Piwowar-Manning, Ryan Kofron
Antimicrobial Agents and Chemotherapy. 2023-04-18 - 5242 citationsPrevention of HIV-1 Infection with Early Antiretroviral TherapyMyron S. Cohen, Ying Q. Chen, Marybeth McCauley, Theresa Gamble, Mina C. Hosseinipour
The New England Journal of Medicine. 2011-08-10
Press Mentions
HIV Incidence: Effect of Universal Testing and TreatmentJuly 17th, 2019
HIV Status May Be Misreported by People Who Inject DrugsJanuary 14th, 2019- HIV-1 Diversity Among Young Women in Rural South Africa: HPTN 068July 5th, 2018
Grant Support
- Impact Of Maternal Haart On Hiv-Infected Breastfeeding Infants: MalawiNational Institute Of Allergy And Infectious Diseases2010–2012
- Laboratory And Statistical Development Of Cross-Sectional HIV Incidence AssaysNational Institute Of Allergy And Infectious Diseases2011
- HIV Prevention Trials Network: Network LaboratoryNational Institute Of Allergy And Infectious Diseases2011
- Resistance In Hiv-Infected Infants After Extended ARV Prophylaxis: Pepi-MalawiEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
- HIV Prevention Trials Network: Network LaboratoryNational Institute Of Allergy And Infectious Diseases2006–2010
- Drug Resistance In Non-Subtype B HIV-1Eunice Kennedy Shriver National Institute Of Child Health &Human Development2002–2005
- V3 Region Diversity In HIV Vertical Transmission: UgandaEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–2000
- V3 Region Diversity In HIV Vertical Transmission: UgandaEunice Kennedy Shriver National Institute Of Child Health &Human Development1996
- Regulation Of Glycoprotein SynthesisNational Institute Of General Medical Sciences1991–1992
